Welcome to PSS 101 Course
We are so glad that you have landed on the PSS 101 Course page! The course is an introductory level course that would be of benefit to anyone who works with medical products (drugs, vaccines, diagnostics or other devices, supplies etc.) and public health programs that rely on them or who is responsible for strengthening related systems (including regulation, pharmacy practices, financing and priority setting, information systems, and appropriate medicine use).
The purpose of the pharmaceutical systems strengthening (PSS) course is to teach participants the basic principles of PSS, including how addressing pharmaceutical system problems advance universal health coverage; combat antimicrobial resistance, HIV and AIDS, malaria, TB, and other public health threats; and promote maternal and child health.
Why is Pharmaceutical Strengthening (PSS) important?
Medical products and related pharmaceutical services that ensure their appropriate use play a critical role in determining health outcomes. However, challenges common in low- and middle-income countries, such as high out-of-pocket expenses and substandard and falsified products, gravely hamper the success of treatments for common diseases. Access to safe and quality products at an affordable price, and their effective use, can help countries prevent maternal and child deaths, create an AIDS-free generation, and protect their communities from infectious diseases, including drug resistance.
As indicated by the US Agency for International Development (USAID), strong pharmaceutical systems are necessary for high-quality health services. However, mismanagement and inappropriate usage are common. An estimated half of all medicines are prescribed, dispensed, sold, or taken inappropriately, and many are of poor quality. Such pharmaceutical systems issues can accelerate development and spread of drug resistance (HIV and AIDS, malaria, tuberculosis) and antimicrobial resistance.
To support pharmacists and health professionals to build their skills and better understand how the complex, comprehensive pharmaceutical system functions, the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program developed this course with a series of hands-on e-learning modules.
The course has ten interactive modules addressing various aspects of the pharmaceutical system. Each module listed below is designed based on adult learning principles, case studies and/or success stories, links to glossary terms, and related resources.
- Module 1: Introduction - Improving access to and appropriate use of medical products and pharmaceutical services
- Module 2: Overview of pharmaceutical systems and pharmaceutical systems strengthening
- Module 3: Bolstering governance in pharmaceutical systems
- Module 4: Improving health outcomes through strengthening pharmaceutical financing systems
- Module 5: Information systems and data
- Module 6: Regulatory systems, PSS, and public health
- Module 7: Supply chain management in the context of PSS and UHC
- Module 8: Ensuring PSS through human resources capacity building
- Module 9: Medical products quality assurance at the global and country levels
- Module 10: Summary module: PSS101 video
Participants who complete the course should be able to:
- Identify what a country pharmaceutical system is, how it relates to the supply chain system, and how it impacts the broader health system (in terms of service quality, coverage equity, and financial protection/resource optimization) as well as improved health outcomes.
- Demonstrate how USAID’s pharmaceutical systems strengthening approach can lead to more sustainable improvements in medicines access and appropriate use to achieve expected health outcomes.
- Explain how the problem can be better understood by looking at the underlying factors contributing to the problem, and how those factors may be linked to one or more pharmaceutical system and/or health system function.
- Compare alternative strategies for interventions to counter problems of the pharmaceutical systems in similar contexts, taking into account the local situation, political and regulatory considerations, feasibility of implementation, and the resources available.
- Identify methods and tools for evaluating pharmaceutical systems to ensure that the expected outcomes have been achieved.
- Identify specific pharmaceutical system weaknesses in USAID-supported countries that have an impact on USAID’s health goals.
This course was developed by the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program and the USAID Office of Health Systems.
- 2 hours
- Sunday, April 3, 2022
- Javier Guzman, Directeur Technique
- Abibata Handley, Conseillère Technique Principale pour la Capacité
- Francis (Kofi) Aboagye-Nyame, Directeur de programme
- Helena Walkowiak, Conseillère Technique Principale
- Emmanuel Nfor, Directeur Technique Adjoint
- Kate Kikule, Conseillère Technique Principale
- Niranjan Konduri, Conseiller Technique Principal
- Kwesi Eghan, Conseiller Technique Principal
- Andrew Brown, Conseiller Technique Principal
- Andrew Brown, Conseiller Technique Principal pour la Gouvernance et le Renforcement des Capacités
- Emmanuel Nfor, Directeur Technique